Form 4 for BIO BIO-RAD LABORATORIES, INC.
Accepted 2023-09-06 00:00:00 ET · period of report 2023-09-01 · accession 0001062993-23-017644 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2023-09-06 | 2023-09-01+ | BIO | Daskal Ilan | EVP, CFO | M - OptEx | $0.00 | +1,692 | 2,755 | +159% | $0 |
| DM | 2023-09-06 | 2023-09-01+ | BIO | Daskal Ilan | EVP, CFO | F - Tax | $394.60 | -718 | 2,486 | -22% | -$283.3K |
| DM | 2023-09-06 | 2023-09-01+ | BIO | Daskal Ilan | EVP, CFO | M - OptEx | $0.00 | -1,692 | 2,082 | -45% | $0 |
| D | 2023-09-06 | 2023-09-01 | BIO | Daskal Ilan | EVP, CFO | A - Grant | $0.00 | +4,007 | 4,007 | New | $0 |
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Bio-Rad A Common Stock | 2023-09-01 | M | A | 694 | $0.00 | 2,206.21 | D | — | — | (F1) Shares of Class A common stock acquired on the vesting of restricted stock units. (F2) Includes 18.9440 shares acquired under the Bio-Rad Employee Stock Purchase Plan on 06/30/2023. |
| 2 | Common | Bio-Rad A Common Stock | 2023-09-01 | F | D | 240 | $394.60 | 1,966.21 | D | — | — | |
| 3 | Common | Bio-Rad A Common Stock | 2023-09-01 | M | A | 456 | $0.00 | 2,422.21 | D | — | — | (F1) Shares of Class A common stock acquired on the vesting of restricted stock units. |
| 4 | Common | Bio-Rad A Common Stock | 2023-09-01 | F | D | 209 | $394.60 | 2,213.21 | D | — | — | |
| 5 | Common | Bio-Rad A Common Stock | 2023-09-02 | M | A | 542 | $0.00 | 2,755.21 | D | — | — | (F1) Shares of Class A common stock acquired on the vesting of restricted stock units. |
| 6 | Common | Bio-Rad A Common Stock | 2023-09-02 | F | D | 269 | $394.60 | 2,486.21 | D | — | — | |
| 7 | Derivative | Restricted Stock Units | 2023-09-02 | M | D | 542 | $0.00 | 542 | D | $0.00 · — to — | 542 Bio-Rad A Common Stock | (F3) Each restricted stock unit represents a contingent right to receive one share of Bio-Rad Class A common stock. (F7) On September 2, 2020, the reporting person was granted 2,166 restricted stock units, vesting in four equal annual installments beginning on the first anniversary of the grant date. |
| 8 | Derivative | Restricted Stock Units | 2023-09-01 | M | D | 456 | $0.00 | 912 | D | $0.00 · — to — | 456 Bio-Rad A Common Stock | (F3) Each restricted stock unit represents a contingent right to receive one share of Bio-Rad Class A common stock. (F6) On September 1, 2021, the reporting person was granted 1,823 restricted stock units, vesting in four equal annual installments beginning on the first anniversary of the grant date. |
| 9 | Derivative | Restricted Stock Units | 2023-09-01 | M | D | 694 | $0.00 | 2,082 | D | $0.00 · — to — | 694 Bio-Rad A Common Stock | (F3) Each restricted stock unit represents a contingent right to receive one share of Bio-Rad Class A common stock. (F5) On September 1, 2022, the reporting person was granted 2,776 restricted stock units, vesting in four equal annual installments beginning on the first anniversary of the grant date. |
| 10 | Derivative | Restricted Stock Units | 2023-09-01 | A | A | 4,007 | $0.00 | 4,007 | D | $0.00 · — to — | 4,007 Bio-Rad A Common Stock | (F3) Each restricted stock unit represents a contingent right to receive one share of Bio-Rad Class A common stock. (F4) The restricted stock units vest over four years at 25% per year on the yearly anniversary date of the grant. |